Literature DB >> 173994

Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.

G G Rhoads, C L Gulbrandsen, A Kagan.   

Abstract

To ascertain the frequency of defined hyperlipoproteinemia and to investigate the relation between lipoprotein fractions and coronary heart disease, we measured serum lipoprotein cholesterol levels in a population-based sample of Hawaii Japanese men 50 to 72 years old. Type II hyperlipoproteinemia was present in 3 per cent of 1859 men, and Type IV in 26 per cent. Relative risks for coronary heart disease, based on 264 prevalence cases, were found to be 1.8, 1.8 and 0.46, between the upper and lower quartiles of total, beta, and alpha cholesterol, respectively. We found no significant relation between triglyceride and coronary heart disease. The inverse relation of alpha cholesterol of prevalence of coronary heart disease was independent of beta cholesterol, obesity, and other factors. The data suggest the need for further evaluation of the protective effect of the alpha lipoprotein fraction on the development of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 173994     DOI: 10.1056/NEJM197602052940601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  104 in total

Review 1.  Tangier disease as a test of the reverse cholesterol transport hypothesis.

Authors:  A R Tall; N Wang
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

3.  Human pedigree-based quantitative-trait-locus mapping: localization of two genes influencing HDL-cholesterol metabolism.

Authors:  L Almasy; J E Hixson; D L Rainwater; S Cole; J T Williams; M C Mahaney; J L VandeBerg; M P Stern; J W MacCluer; J Blangero
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

4.  Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.

Authors:  Urbain Tchoua; Corina Rosales; Daming Tang; Baiba K Gillard; Ashley Vaughan; Hu Yu Lin; Harry S Courtney; Henry J Pownall
Journal:  Lipids       Date:  2010-10-24       Impact factor: 1.880

5.  A genomewide search using an original pairwise sampling approach for large genealogies identifies a new locus for total and low-density lipoprotein cholesterol in two genetically differentiated isolates of Sardinia.

Authors:  Mario Falchi; Paola Forabosco; Evelina Mocci; Cesare Cappio Borlino; Andrea Picciau; Emanuela Virdis; Ivana Persico; Debora Parracciani; Andrea Angius; Mario Pirastu
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

Review 6.  Plasma lipoproteins, lipid transport, and atherosclerosis: recent developments.

Authors:  N E Miller
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

7.  Effects of prazosin and alphamethyldopa on blood lipids and lipoproteins in hypertensive patients.

Authors:  M Velasco; H Silva; E Feldstein; R Pellicer; J Morillo; A Urbina-Quintana; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men.

Authors:  M Stalder; D Pometta; A Suenram
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

9.  Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

Authors:  A Inazu; X C Jiang; T Haraki; K Yagi; N Kamon; J Koizumi; H Mabuchi; R Takeda; K Takata; Y Moriyama
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase.

Authors:  J R Patsch; S Prasad; A M Gotto; G Bengtsson-Olivecrona
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.